Variable | Patients (TIDM) N (%) | Control N (%) | Adjusted OR | 95% CI | p value |
---|---|---|---|---|---|
PDL-1 rs4143815 C/G | |||||
General model | |||||
CC | 2 (2.5%) | 4 (5.3%) | 1 | ||
CG | 30 (37.5%) | 32 (42.1%) | 34.9 | 0.672–1819.1 | 0.078 |
GG | 48 (60.0%) | 40 (52.6%) | 47.2 | 0.924–2414.88 | 0.055 |
Dominant model | |||||
CC | 2 (2.5%) | 4 (5.3%) | 42.8 | 0.847–2169 | 0.061 |
CG + GG | 78 (97.5%) | 72 (94.7%) | |||
Recessive model | |||||
GG | 48 (60.0%) | 40 (52.6%) | 1.61 | 0.815–3.213 | 0.169 |
CC + GC | 32 (40.0%) | 36 (47.4%) | |||
PDL-1 rs2297137 A/G | |||||
General model | |||||
AA | 2 (2.5%) | 4 (5.3%) | 1 | ||
GA | 24 (30.0%) | 28 (36.8%) | 3.52 | 0.334–37.24 | 0.295 |
GG | 54 (67.5%) | 44 (57.9%) | 9.59 | 0.914–100.5 | 0.059 |
Dominant model | |||||
AA | 2 (2.5%) | 4 (5.3%) | 6.25 | 0.676–57.1 | 0.106 |
GA + GG | 78 (97.5) | 72 (94.7%) | |||
Recessive model | |||||
GG | 54 (67.5%) | 44 (57.9%) | 3.01 | 1.35–6.69 | 0.007 |
AA + GA | 26 (32.5%) | 32 (42.1%) |